Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

ASCO Direct Highlights: 2020 Official Annual Meeting Review

Release Date: August 6, 2020
Expiration Date: August 6, 2021

Activity Overview

Community Practice Connections™: ASCO Direct Highlights provides concise summaries and expert commentary on key clinical studies presented at the virtual oncology meeting in May 2020. This activity includes interactive clinical vignettes and questions related to the application of recent clinical trials, followed by short video interviews with leading experts in the management of patients with cancer. The video interviews address decision points in the clinical vignettes, as well as questions commonly faced in the community oncology practice setting by health care professionals engaged in the care of patients with cancer.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.


Target Audience

This educational activity is directed toward medical oncologists, as well as surgical oncologists, nurses, and pathologists. Nurse practitioners (NPs), physician assistants (PAs), pharmacists, researchers, and other health care professionals may also participate.

Learning Objectives

Upon successful completion of this educational activity, you should be better prepared to:

  • discuss how the evaluation of molecular characteristics of solid tumors and hematologic malignancies has been incorporated into the design of recent clinical trials
  • analyze recent data on the efficacy and safety of therapeutic options for the treatment of solid tumors and hematologic malignancies
  • design optimal treatment strategies for the management of patients with solid tumors and hematologic malignancies, based on recent clinical trial findings.

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Program Chair

Leora Horn, MD, MSc
Leora Horn, MD, MSc
Associate Professor of Medicine
Assistant Vice Chairman for Faculty Development
Clinical Director, Thoracic Oncology Program
Vanderbilt University Medical Center
Nashville, TN

Disclosures: Grant Research Support: Xcovery LLC, Bristol Myers Squibb Co, Boehringer Ingelheim Pharmaceuticals Inc; Consultant: AstraZeneca plc, Amgen Inc, EMD Serono Inc, Incyte Corporation, Genentech Inc, Pfizer Inc, Xcovery LLC; Other: Travel support – Xcovery LLC.

Faculty

Yelena Y. Janjigian, MD
Yelena Y. Janjigian, MD
Associate Professor of Medicine
Weill Cornell Medical College
Associate Attending Physician, GI Service
Memorial Hospital for Cancer and Allied Diseases
Chief, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures: Grant Research Support: Boehringer Ingelheim Pharmaceuticals Inc, Bayer AG, Genentech Inc/F. Hoffman La-Roche Ltd, Bristol Myers Squibb Co, Eli Lilly and Company, Merck & Co Inc, Amgen Inc; Consultant: Merck Serono SA, Bristol Myers Squibb Co, Eli Lilly and Company, Pfizer Inc, Bayer AG, Imugene Ltd, Merck & Co Inc, Daiichi Sankyo Co Ltd, AstraZeneca Inc, Seattle Genetics Inc, Zymeworks Inc

Michael A. Postow, MD
Michael A. Postow, MD
Melanoma Service
Memorial Sloan Kettering Cancer Center
New York, NY

Disclosures: Grant Research Support: Bristol Myers Squibb Co Novartis AG, Merck & Co Inc, Array BioPharma, Rgenix Inc, Infinity Pharmaceuticals Inc; Consultant: Bristol Myers Squibb Co, Novartis AG, NewLink Genetics, Incyte Corp, Array BioPharma, Merck & Co Inc, Aduro Biotech Inc; Other: Honoraria from Merck & Co Inc and Bristol Myers Squibb Co

Brian Rini, MD
Brian Rini, MD
Ingram Professor of Medicine
Vanderbilt-Ingram Cancer Center
Nashville, TN

Disclosures: Grant Research Support: Pfizer Inc, Merck & Co Inc, Genentech Inc, AVEO Pharmaceuticals Inc, AstraZeneca Inc; Consultant: Merck & Co Inc, Pfizer Inc, Bristol Myers Squibb Co, Aravive Inc, 3D Medicines Corp, Synthorx Inc; Shareholder: PTC Therapeutics Inc

Joyce O’Shaughnessy, MD
Joyce O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Texas Oncology
Chair, Breast Cancer Prevention Research
Texas Oncology-Baylor Charles A. Sammons Cancer Center
Dallas, TX

Disclosures: Consultant: Novartis AG, AstraZeneca Inc, Celgene Corp, Eli Lilly and Company, Merck & Co Inc, Pfizer Inc, Seattle Genetics Inc

Saad Zafar Usmani, MD, FACP
Saad Zafar Usmani, MD, FACP
Division Chief, Plasma Cell Disorders
Director, Clinical Research in Hematologic Malignancies
Levine Cancer Institute, Atrium Health
Charlotte, NC

Disclosures: Grant Research Support: Amgen Inc, Array BioPharma, Bristol Myers Squibb Co, Celgene Corp, Janssen Pharmaceuticals Inc, Merck & Co Inc, Pharmacyclics LLC, Sanofi SA, Takeda Pharmaceutical Company Ltd, Incyte Corp, Seattle Genetics Inc, GlaxoSmithKline plc; Consultant: Amgen Inc, Celgene Corp, Janssen Pharmaceuticals Inc, Merck & Co Inc, Bristol Myers Squibb plc, SkylineDX BV, Takeda Pharmaceutical Company Ltd, GlaxoSmithKline plc; Speakers Bureau: Amgen Inc, Celgene Corp, Janssen Pharmaceuticals Inc, Takeda Pharmaceutical Company Ltd, Sanofi SA

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.


Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
  12345
6789101112
13141516171819
20212223242526
27282930
Filter By